BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 9714110)

  • 21. Alterations in the pattern of collagen deposition may contribute to the deterioration of systolic function in hypertensive patients with heart failure.
    López B; González A; Querejeta R; Larman M; Díez J
    J Am Coll Cardiol; 2006 Jul; 48(1):89-96. PubMed ID: 16814653
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Insulin-like growth factor-1 and cardiac mass in essential hypertension: comparative effects of captopril, lisinopril and quinapril.
    Díez J; Laviades C
    J Hypertens Suppl; 1994 Jul; 12(4):S31-6. PubMed ID: 7965272
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Collagen type-I degradation is related to arterial stiffness in hypertensive and normotensive subjects.
    McNulty M; Mahmud A; Spiers P; Feely J
    J Hum Hypertens; 2006 Nov; 20(11):867-73. PubMed ID: 16598292
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in hypertension and their relationship to cardiovascular risk and treatment: a substudy of the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT).
    Tayebjee MH; Nadar S; Blann AD; Gareth Beevers D; MacFadyen RJ; Lip GY
    Am J Hypertens; 2004 Sep; 17(9):764-9. PubMed ID: 15363817
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Plasma levels of active extracellular matrix metalloproteinases 2 and 9 in patients with essential hypertension before and after antihypertensive treatment.
    Zervoudaki A; Economou E; Stefanadis C; Pitsavos C; Tsioufis K; Aggeli C; Vasiliadou K; Toutouza M; Toutouzas P
    J Hum Hypertens; 2003 Feb; 17(2):119-24. PubMed ID: 12574790
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Filling pressures and collagen metabolism in hypertensive patients with heart failure and normal ejection fraction.
    González A; López B; Querejeta R; Zubillaga E; Echeverría T; Díez J
    Hypertension; 2010 Jun; 55(6):1418-24. PubMed ID: 20404218
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Circulating biomarkers of collagen metabolism in arterial hypertension: relevance of target organ damage.
    Morillas P; Quiles J; de Andrade H; Castillo J; Tarazón E; Roselló E; Portolés M; Rivera M; Bertomeu-Martínez V
    J Hypertens; 2013 Aug; 31(8):1611-7. PubMed ID: 23615327
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Ventricular remodeling and matrix metalloproteinase-1 and its tissue inhibitor of metalloproteinase-1 in serum in third trimester of pregnant women with cardiac disease.].
    Zhang ZL; Lin JH; Tao RQ
    Zhonghua Fu Chan Ke Za Zhi; 2009 Oct; 44(10):731-5. PubMed ID: 20078957
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evidence for altered hepatic matrix degradation in genetic haemochromatosis.
    George DK; Ramm GA; Powell LW; Fletcher LM; Walker NI; Cowley LL; Crawford DH
    Gut; 1998 May; 42(5):715-20. PubMed ID: 9659170
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Insulin-like growth factor I and collagen type III synthesis in patients with essential hypertension and left ventricular hypertrophy.
    Diéz J; Laviades C
    J Hum Hypertens; 1994 Sep; 8 Suppl 1():S21-5. PubMed ID: 7807509
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of ACE inhibition versus non-ACE inhibitor antihypertensive treatment on myocardial fibrosis in patients with arterial hypertension. Retrospective analysis of 120 patients with left ventricular endomyocardial biopsies.
    Brilla CG; Rupp H; Maisch B
    Herz; 2003 Dec; 28(8):744-53. PubMed ID: 14689110
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of the metalloproteinase-9/tissue inhibitor of metalloproteinase-1 system on large arterial stiffness in patients with essential hypertension.
    Tan J; Hua Q; Xing X; Wen J; Liu R; Yang Z
    Hypertens Res; 2007 Oct; 30(10):959-63. PubMed ID: 18049028
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Changes in metalloproteinases in healthy normotensive patients with high-normal blood pressure.
    Papadopoulos DP; Makris TK; Krespi PG; Poulakou M; Papazachou OG; Hatzizacharias AN; Perrea D; Votteas V
    Eur Cytokine Netw; 2005 Sep; 16(3):211-4. PubMed ID: 16266862
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Time dependent alterations of serum matrix metalloproteinase-1 and metalloproteinase-1 tissue inhibitor after successful reperfusion of acute myocardial infarction.
    Hirohata S; Kusachi S; Murakami M; Murakami T; Sano I; Watanabe T; Komatsubara I; Kondo J; Tsuji T
    Heart; 1997 Sep; 78(3):278-84. PubMed ID: 9391291
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The impact of angiotensin-converting enzyme inhibitor therapy on the extracellular collagen matrix during left ventricular assist device support in patients with end-stage heart failure.
    Klotz S; Danser AH; Foronjy RF; Oz MC; Wang J; Mancini D; D'Armiento J; Burkhoff D
    J Am Coll Cardiol; 2007 Mar; 49(11):1166-74. PubMed ID: 17367660
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Circulating levels of matrix metalloproteinases MMP-3 and MMP-1, tissue inhibitor of metalloproteinases 1 (TIMP-1), and MMP-1/TIMP-1 complex in rheumatic disease. Correlation with clinical activity of rheumatoid arthritis versus other surrogate markers.
    Keyszer G; Lambiri I; Nagel R; Keysser C; Keysser M; Gromnica-Ihle E; Franz J; Burmester GR; Jung K
    J Rheumatol; 1999 Feb; 26(2):251-8. PubMed ID: 9972954
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Elevated serum levels of type I collagen degradation marker ICTP and tissue inhibitor of metalloproteinase (TIMP) 1 are associated with poor prognosis in lung cancer.
    Ylisirniö S; Höyhtyä M; Mäkitaro R; Pääakkö P; Risteli J; Kinnula VL; Turpeenniemi-Hujanen T; Jukkola A
    Clin Cancer Res; 2001 Jun; 7(6):1633-7. PubMed ID: 11410500
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Myocardial Collagen Cross-Linking Is Associated With Heart Failure Hospitalization in Patients With Hypertensive Heart Failure.
    López B; Ravassa S; González A; Zubillaga E; Bonavila C; Bergés M; Echegaray K; Beaumont J; Moreno MU; San José G; Larman M; Querejeta R; Díez J
    J Am Coll Cardiol; 2016 Jan; 67(3):251-60. PubMed ID: 26796388
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression of collagen, interstitial collagenase, and tissue inhibitor of metalloproteinases-1 in restenosis after carotid endarterectomy.
    Nikkari ST; Geary RL; Hatsukami T; Ferguson M; Forough R; Alpers CE; Clowes AW
    Am J Pathol; 1996 Mar; 148(3):777-83. PubMed ID: 8774133
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Metabolism of collagen is altered in hypertensives with increased intima media thickness.
    Szmigielski C; Raczkowska M; Styczynski G; Pruszczyk P; Gaciong Z
    Blood Press; 2006; 15(3):157-63. PubMed ID: 16864157
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.